Two Sigma Advisers’s 1Life Healthcare ONEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-171,400
Closed -$1.34M 2799
2022
Q2
$1.34M Sell
171,400
-130,900
-43% -$1.12M ﹤0.01% 1440
2022
Q1
$3.35M Sell
302,300
-390,600
-56% -$4.37M 0.01% 986
2021
Q4
$12.2M Sell
692,900
-393,500
-36% -$7.63M 0.03% 444
2021
Q3
$22M Buy
1,086,400
+488,100
+82% +$12.5M 0.06% 297
2021
Q2
$19.8M Sell
598,300
-219,300
-27% -$8.28M 0.05% 338
2021
Q1
$32M Buy
817,600
+93,500
+13% +$4.39M 0.09% 246
2020
Q4
$31.6M Buy
724,100
+380,200
+111% +$13M 0.08% 246
2020
Q3
$9.75M Buy
+343,900
New +$10.9M 0.03% 537

Other funds holding ONEM

Two Sigma Advisers's ONEM Position: Q3 2022 in Review

Two Sigma Advisers sold out of 1Life Healthcare (ONEM) in Q3 2022, closing a stake of 171,400 shares — an estimated $1.34M sold.

Two Sigma Advisers first reported a position in ONEM in Q3 2020 and held it in 8 quarters. The position peaked at $32M in Q1 2021. 222 funds tracked by Wall St. Rank hold ONEM as of Q3 2022.

  • Two Sigma Advisers reported no remaining 1Life Healthcare position as of Q3 2022 after selling out during the quarter.
  • Two Sigma Advisers sold 171,400 1Life Healthcare shares in Q3 2022, an estimated $1.34M.
  • Two Sigma Advisers first reported a position in 1Life Healthcare in Q3 2020 and held it in 8 quarters.
  • Two Sigma Advisers's 1Life Healthcare position peaked at $32M in Q1 2021.
  • 222 funds tracked by Wall St. Rank held 1Life Healthcare as of Q3 2022.

Based on Two Sigma Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.